Search

AEROSIL® fumed silica for pharmaceuticals

Pharma Silica AEROSIL

Cost-effective and reliable manufacturing methods are an absolute must for today's pharmaceutical industry. This is just one reason why AEROSIL® fumed silica has become one of the most important and frequently used pharmaceutical excipients. Improving flow properties of starting materials required for modern tablet and capsule manufacture is just one example of the advantages gained by use of AEROSIL® fumed silica. It can also considerably improve the manufacturing as well as properties of many other drug forms.

AEROSIL® colloidal silicon dioxide has been used in the pharmaceutical industry for almost 50 years. Since the original AEROSIL® 200 we have expanded our portfolio with special pharmaceutical grades available in different surface areas, hydrophilic and hydrophobic, as well as granulated types.

Our objective is to provide our customers with the optimum solution for their systems, to meet their high standard and to make their products even more successful.

Video - Tableting with Moisture-Activated Dry Granulation

External Source (IFrame)
AEROSIL® for Pharmaceuticals

File

Language

AEROSIL® Pharma - One quality for food and pharma applications  (pdf, 455 KB)

In times of increasing product rationalization, expanding quality requirements and easy powder handling for food and pharma applications our customer can now benefit from the enhanced quality of AEROSIL® 200 Pharma. Different quality standards are now combined in one product providing HACCP and IPEC-GMP! Capitalize the advantage of AEROSIL® 200 Pharma for your food and pharma production.

EN

Fact Sheet: AEROSIL® for dental composites  (pdf, 342 KB)

AEROSIL® fumed silica increase the hardness and abrasivity resistance of dental composites. In addition, they reduce the edge gap that can occur when the composite is cured.

EN

Technical Information 1414: AEROPERL® 300 Pharma Improving the dissolution of poorly soluble APIs  (pdf, 943 KB)

AEROPERL® 300 Pharma colloidal silicon dioxide: our solution to the solubility challenge of active pharmaceutical ingredients.

EN

Technical Information 1415: AEROSIL® and AEROPERL® Pharma Colloidal Silicon Dioxide Products  (pdf, 820 KB)

AEROSIL® colloidal silicon dioxide has been used as a pharmaceutical excipient since the early days of direct compression tableting. AEROSIL® 200 Pharma is the traditional glidant, helping to obtain the optimal powder fl ow required by today’s high speed tablet presses. Since the time that AEROSIL® 200 Pharma was fi rst used as a glidant, challenges in formulating solid dosage forms have become more complex. Tablet powders of diff erent average particle size, composition and moisture sensitivity are common in the industry – requiring specialized products to be able to compete in an increasingly cost sensitive health care environment.

EN

Technical Information 1424: AEROSIL® Pharma colloidal silicon dioxide  (pdf, 1.23 MB)

Designed for improved powder flow and cost efficient solid dosage form production.

EN

Pharma Silica Insights, Issue 1  (pdf, 336 KB)

The first edition of our "Pharma Silica Insights" newsletter introduces AEROPERL® 300 Pharma as the latest addition to our AEROSIL® Pharma portfolio and how this product can be used to increase the solubility of poorly soluble active pharmaceutical ingredients.

EN

Pharma Silica Insights, Issue 2  (pdf, 1.25 MB)

Topic: - AEROSIL® and AEROPERL® colloidal silicon dioxide pave the way to ICH Q3D compliant formulations

EN